7Baggers
 Published on: 2025-11-16 12:37:31  newser.com Sun, 16 Nov 2025 18:37:31 GMT
 lineage therap sells 12 million shares to janus  The Globe and Mail Thu, 13 Nov 2025 15:29:26 GMT
 Lineage Cell Therapeutics: OpRegen Makes It A Viable Speculative Buy  Seeking Alpha Thu, 13 Nov 2025 09:10:31 GMT
 lineage therap sells 12 million shares to janus  TipRanks Wed, 12 Nov 2025 14:48:26 GMT
 published on: 2025-11-11 05:15:53  newser.com Tue, 11 Nov 2025 11:15:53 GMT
 lineage cell therapeutics: progress amid financial challenges  TipRanks Sat, 08 Nov 2025 00:56:44 GMT
 lineage cell therapeutics earnings missed by $0.11, revenue topped estimates  Investing.com India Fri, 07 Nov 2025 10:21:45 GMT
 Lineage Cell Therapeutics: Progress Amid Financial Challenges  TipRanks Fri, 07 Nov 2025 08:00:00 GMT
 lineage cell therapeutics reports q3 2025 results  TipRanks Fri, 07 Nov 2025 05:30:35 GMT
 Lineage Cell Therapeutics reports Q3 EPS (13c), consensus (3c)  TipRanks Fri, 07 Nov 2025 03:57:11 GMT
 Lineage Cell: Q3 Earnings Snapshot  Norwalk Hour Fri, 07 Nov 2025 00:49:07 GMT
 Lineage Cell Therapeutics Reports Q3 2025 Results  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 Lineage Cell: Q3 Earnings Snapshot  San Francisco Chronicle Thu, 06 Nov 2025 08:00:00 GMT
 Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates  sharewise.com Thu, 06 Nov 2025 08:00:00 GMT
 published on: 2025-11-05 22:49:18  newser.com Thu, 06 Nov 2025 04:49:18 GMT
 Lineage Cell Therapeutics Hits New 52-Week High of $2.09  Markets Mojo Wed, 05 Nov 2025 15:19:37 GMT
 published on: 2025-11-10 07:09:42  newser.com Wed, 05 Nov 2025 06:49:42 GMT
 Lineage Cell Therapeutics Hits New 52-Week High of $1.95  Markets Mojo Tue, 04 Nov 2025 10:38:13 GMT
 published on: 2025-11-03 06:28:30  newser.com Mon, 03 Nov 2025 12:28:30 GMT
 lineage cell therapeutics hits new 52-week high of $1.87  Markets Mojo Sun, 02 Nov 2025 10:24:27 GMT
 published on: 2025-11-02 02:45:07  newser.com Sun, 02 Nov 2025 07:45:07 GMT
 how lineage cell therapeutics inc. stock reacts to fed tightening  newser.com Sun, 02 Nov 2025 06:35:00 GMT
 lineage cell therapeutics hits new 52-week high of $1.87  Markets Mojo Fri, 31 Oct 2025 20:08:04 GMT
 published on: 2025-10-31 03:43:26  newser.com Fri, 31 Oct 2025 08:43:26 GMT
 published on: 2025-10-31 01:13:04  newser.com Fri, 31 Oct 2025 06:13:04 GMT

Lineage Cell Therapeutics, Inc
(NYSE MKT:LCTX) 

LCTX stock logo

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapies for the treatment of degenerative diseases in the United States and internationally. The company's lead product candidates include OpRegen, a retinal pigment epithelium cell r...

Full Time Employees: 50
CEO: Brian M. Culley  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends